Globus Medical (GMED) Tops Q2 EPS by 12c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
Globus Medical (GMED) PT Raised to $100 at Northland Capital Markets
August 5, 2021 7:36 AM EDTNorthland Capital Markets analyst Jason Wittes raised the price target on Globus Medical (NYSE: GMED) to $100.00 while maintaining an Outperform rating.
The analyst commented, "GMED reported record revenues in 2Q21 of $251.0 million, up 68.6% y/y (up 67.9% cc y/y), easily beating consensus of... More
Globus Medical (GMED) PT Raised to $89 at Truist Securities
August 5, 2021 6:29 AM EDTTruist Securities analyst Samuel Brodovsky raised the price target on Globus Medical (NYSE: GMED) to $89.00 (from $82.00) while maintaining a Buy rating.
The analyst commented, "GMED announced 2Q results that saw revenue comfortably beat the Street. Guidance was raised on both... More
